खोज
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
WHO stakeholder survey on improving access to morphine for medical use
WHO launched a survey on assessing barriers, enablers, and pirority actions for improving access to morphine for medical use.
All Civil Society Organisation can contribute by filling out the survey before 31 August 2022.
The survey is...
Лекция 1: Центральноазиатский цикл открытых лекций по скринингу, оценке и лечению расстройств, связанных с употреблением психоактивных веществ
Открытые лекции будут проводиться по совместной инициативе ISSUP Ukraine, ISSUP Kazakhstan и ITTC Ukraine.
Национальный круглый стол по завершенному исследованию распространенности новых психоактивных веществ
Приглашаем специалистов Министерства здравоохранения РК, Министерства внутренних дел РК, Казахского научного центра дерматологии и инфекционных заболеваний, представителей UNODC, UNAIDS, неправительственных организаций, руководителей и врачей региональных Центров психического здоровья.
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Background
In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly...
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
Background
Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the...
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Paper presented at the commemoration of the 2022 International Day Against Drug Abuse & Illicit Trafficking, State House Conference Centre, Abuja, Nigeria.
The UNODC/PTRS demand reduction mentor at the UNODC Programme Office in Indonesia provided technical assistance to the National Narcotics Board (BNN) in conducting a national hybrid training for Government Officials on the UNODC Treatnet Family programme
On July 19th, 2022, the Director of Strengthening Government Institution, Deputy of Rehabilitation, BNN officially launched a national hybrid training on the UNODC Treatnet Family programme with 34 representatives from all BNN provinces and...
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Thirteenth Session)
ISSUP Nigeria would like to invite you to attend their next Bi-Monthly Webinar in the Knowledge Update Series. The Webinar topic will be Beyond Dependence: Alcohol-induced Disorders.
Learning Outcomes:
• Sensitization to the wide range...
Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride
Objectives: Positron emission tomography (PET) with [11C]raclopride has been applied to measure changes in the concentration of endogenous dopamine induced by pharmacological challenge or neuropsychological stimulation by evaluating the...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how workers...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in the...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
Ecolink Institute opens UTC training in Hindi
Ecolink Institute starts UTC training in Hindi
Mangalore: The Mangalore based Ecolink Institute of well-being, an approved training provider of the Colombo Plan has started a special training on “Understanding addiction and its treatment...
New psychoactive substances (NPS) - the Irish situation.
This factsheet summarises information and statistics on new psychoactive substances gathered from recent reports on prevalence, treatment, mortality and legislation in Ireland.
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
World Drug Report 2022
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
Another Milestone for Kenya: Launch of the National Standard on Management of Persons with Substance Use Disorders
According to the International Standards for the Treatment of Drug Use Disorders (2020), the use of psychoactive drugs or narcotic drugs and psychotropic substances without medical supervision is associated with significant health risks...
